Literature DB >> 12125962

ALA- and ALA-ester-mediated photodynamic therapy of human glioma spheroids.

Henry Hirschberg1, Chung-Ho Sun, Bruce J Tromberg, Steen J Madsen.   

Abstract

The effects of photodynamic therapy (PDT) in human glioma spheroids incubated in 5-aminolevulinic acid (ALA), or ALA esters, are investigated. Spheroid survival and growth are monitored following PDT at representative drug concentrations, light doses, and dose rates. The primary finding of this study is that the response of human glioma spheroids to PDT with lipophilic ester derivatives, such as benzyl-ALA and hexyl-ALA, is equivalent to that observed with ALA, however, this equivalency is obtained for ester concentrations 10-20 times lower than the parent compound. The enhanced efficiency of the esters is likely due to their increased membrane penetrance. Potential clinical advantages of using lipophilic esters in PDT of gliomas are discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12125962     DOI: 10.1023/a:1015784926550

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  24 in total

1.  An indwelling brachytherapy balloon catheter: potential use as an intracranial light applicator for photodynamic therapy.

Authors:  H Hirschberg; S Madsen; K Lote; T Pham; B Tromberg
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence.

Authors:  W Stummer; S Stocker; S Wagner; H Stepp; C Fritsch; C Goetz; A E Goetz; R Kiefmann; H J Reulen
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

3.  5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells.

Authors:  P Uehlinger; M Zellweger; G Wagnières; L Juillerat-Jeanneret; H van den Bergh; N Lange
Journal:  J Photochem Photobiol B       Date:  2000-01       Impact factor: 6.252

4.  Optical properties of human brain.

Authors:  L O Svaasand; R Ellingsen
Journal:  Photochem Photobiol       Date:  1983-09       Impact factor: 3.421

5.  Photodynamic therapy of human glioma spheroids using 5-aminolevulinic acid.

Authors:  S J Madsen; C H Sun; B J Tromberg; V P Wallace; H Hirschberg
Journal:  Photochem Photobiol       Date:  2000-07       Impact factor: 3.421

6.  Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach.

Authors:  A Marti; N Lange; H van den Bergh; D Sedmera; P Jichlinski; P Kucera
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

7.  Prodrugs of 5-aminolevulinic acid for photodynamic therapy.

Authors:  J Kloek
Journal:  Photochem Photobiol       Date:  1996-12       Impact factor: 3.421

8.  Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

Authors:  K E Wallner; J H Galicich; G Krol; E Arbit; M G Malkin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-06       Impact factor: 7.038

9.  Photodynamic therapy for recurrent supratentorial gliomas.

Authors:  P J Muller; B C Wilson
Journal:  Semin Surg Oncol       Date:  1995 Sep-Oct

10.  Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.

Authors:  N Lange; P Jichlinski; M Zellweger; M Forrer; A Marti; L Guillou; P Kucera; G Wagnières; H van den Bergh
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  1 in total

1.  Aminolevulinic acid-mediated photodynamic therapy of human meningioma: an in vitro study on primary cell lines.

Authors:  Mustafa El-Khatib; Carolin Tepe; Brigitte Senger; Maxine Dibué-Adjei; Markus Johannes Riemenschneider; Walter Stummer; Hans Jakob Steiger; Jan Frédérick Cornelius
Journal:  Int J Mol Sci       Date:  2015-04-30       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.